Dawn Adams

Mrs. Dawn Adams

Ulster University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2025 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
SHStefanie Hossmann
Stefanie Hossmann
STSusanne Tan
Susanne Tan
Julia MaderJulia Mader
Julia Mader
DKDavid C. Klonoff
David C. Klonoff
Dawn AdamsDawn Adams
Dawn Adams
MRMartina Rothenbühler
Martina Rothenbühler
Incorporating sex-specific factors in diabetes research and treatment is essential for advancing precision medicine. There are critical gaps in understanding and applying sex-related differences. Female-specific diabetes pathophysiology manifests in three major areas: life cycle phases (including puberty, pregnancy, and menopause), lifestyle factors (such as responses to nutrition and physical activity), and insulin pharmacology. These elements significantly affect insulin sensitivity and glycemic control in women, yet are frequently underrepresented or ignored in both research and clinical practice. Greater research and clinical focus across these domains is needed to better understand and address sex-based differences in diabetes. Identifying and filling evidence gaps will support more systematic and effective care.

1 November 2021 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
Dawn AdamsDawn Adams
Dawn Adams
ENEjay Nsugbe
Ejay Nsugbe
Diabetes is a chronic non-communicable disease resulting from pancreatic inability to produce the hormone insulin, or a physiological cellular inability to use this hormone effectively. This leads to unregulated blood glucose levels, which can cause significant and often irreversible physiological damage. Current means of glucose level monitoring range from infrequent capillary blood glucose sampling to continuous interstitial fluid glucose monitoring. However, the accuracy of these methods is limited by numerous factors. A potential solution to this shortcoming involves the use of wearable sensors that record an individual’s physiological responses to a range of daily activities, which are subsequently fused and processed with machine learning (ML) algorithms to provide a prediction of an individual’s glucose level and can provide an artificial intelligence-driven glucose monitoring platform. In this paper, we conduct a comparison case study using quadratic discriminant analysis (QDA) and support vector machine (SVM) algorithms for the classification of glucose levels with data acquired from the wearable sensors of a type 1 diabetic individual. Preliminary results demonstrate predicted glucose levels with >70% accuracy, indicating potential for this approach to be used in the design of an ergonomic glucose prediction platform utilizing wearable sensors. Further work will involve the exploration of additional datasets from affordable wearables to enhance and improve the prediction power of the ML algorithms.

1 November 2022 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
ENEjay Nsugbe
Ejay Nsugbe
JRJosé Javier Reyes-Lagos
José Javier Reyes-Lagos
Dawn AdamsDawn Adams
Dawn Adams
Oluwarotimi Williams SamuelOluwarotimi Williams Samuel
Oluwarotimi Williams Samuel
MAMojisola Grace Asogbon
Mojisola Grace Asogbon
MPMichael Provost
Michael Provost
Preterm pregnancies are one of the leading causes of morbidity and mortality amongst children under the age of five. This is a global issue and has been identified as an area requiring active research. The emphasis now is to identify and develop methods of predicting the likelihood of preterm birth. This paper uses physiological data from a group of patients in active labor. The dataset contains information about fetal heart rate (FHR) and maternal heart rate (MHR) for all patients and electrohysterogram (EHG) recordings for the measurement of uterine contractions. For the physiological data analysis and associated signal processing, we utilize deep wavelet scattering (DWS). This is an unsupervised decomposition and feature extraction method combining characteristics from deep learning convolutions, as well as the classical wavelet transform, to observe and investigate the extent to which active preterm labor can be accurately identified from an acquired physiological signal, the results of which were compared with the metaheuristic linear series decomposition learner (LSDL). Additional machine learning algorithms are tested on the acquired physiological data to allow for the identification of optimal model architecture for this specific physiological data.

1 November 2021 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
ENEjay Nsugbe
Ejay Nsugbe
Oluwarotimi Williams SamuelOluwarotimi Williams Samuel
Oluwarotimi Williams Samuel
ISIbrahim Sanusi
Ibrahim Sanusi
SVSuresh Vishwakarma
Suresh Vishwakarma
Dawn AdamsDawn Adams
Dawn Adams
To date, effective means of predicting pregnancy labor continues to lack. Magnetic field signals during uterine contraction have shown, in recent studies, to be a good source of information for predicting labor state with a greater accuracy compared with existing methods. The means of labor prediction methods from such signals appear to rely on a supervised learning post-processing framework whose calibration relies on an effective labelling of the training sample set. As a potential solution to this, using a reduced electrode channel from magnetomyography instrumentation, we propose a multi-stage self-sorting cybernetic model that is comprised of an ensemble of various post-processing methods, and is underpinned by an unsupervised learning framework that allows for an automated method towards learning from the trend in the data to infer labor state and imminency. Experimental results showed a comparable accuracy with those from a supervised learning method adopted in a prior study. Additionally, an architecture of how an intelligent cybernetic model can be used for labor prediction and cost saving benefits within a clinical setting is offered by this study.

22 August 2026 in Diabetic Medicine
Verified
Journal Article
Open access
RBRachel Black
Rachel Black
FHFelicity Hasson
Felicity Hasson
LKLisa King
Lisa King
MDMark Davies
Mark Davies
DMDeborah Muldrew
Deborah Muldrew
VCVivien Coates
Vivien Coates
Aims: To identify, appraise and synthesise the current evidence relating to symptoms, experiences, management and impact of menopause on QoL among women with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) and to identify evidence gaps. Methods: We conducted a scoping review guided by Arksey and O'Mally's framework by searching CINAHL, MEDLINE, EMBASE, PsychINFO and PubMed using an iterative approach to pre‐specified eligibility criteria which were reviewed with increasing familiarity with the literature. Studies focusing on peri‐menopausal and menopausal people assigned female at birth with a diagnosis of T1DM or T2DM were included. Results: In total, 16,681 records were identified from which 77 papers were subjected to full review, with 22 eligible. Research focus and methodology varied: 16 observational studies, 2 expert consensus reviews, 2 interventional studies, 1 patient and public involvement paper and 1 qualitative grounded theory paper. PRISMA‐ScR guidelines were followed for transparency of reporting. Findings indicate women with diabetes experience menopausal symptoms similar to those of women without diabetes; however, they may be at risk of increased severity of symptoms, HRT use was linked to lower HbA1c levels but is largely overlooked, limited research has been undertaken exploring women's experiences and awareness of support during the menopause; existing research evidence suggests they are ill‐informed and lacking effective evidence based support. There is a particular dearth of evidence relating to women with T1DM. Conclusions: This review provides evidence that menopause has a negative influence upon quality of life for many women with diabetes. The impacts span managing diabetes and menopausal symptoms and seeking and receiving support. A hypothesised bidirectional relationship between diabetes and menopause may exist: whereby progression of one may be influenced by the other also resulting in a lower quality of life. While high‐level evidence on this complex inter‐relationship remains limited, particularly in T1DM populations, it suggests significant unmet need for those experiencing diabetes and menopause together.

1 November 2022 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
Dawn AdamsDawn Adams
Dawn Adams
ENEjay Nsugbe
Ejay Nsugbe
Menopause is an under-reported and under-researched life stage for women living with type 1 diabetes (T1D) despite its lasting approximately 20 years. Menopause is associated with metabolic dysfunction leading to weight gain, impaired insulin sensitivity, hypertension, and hypercholesterolemia, each of which diminishes longevity for women living with diabetes. Its symptoms, affecting cognition, sleep patterns, mood, cardiac and vascular health, and physical health, are known to impact glucose variability dynamics. Associated vasomotor symptoms of hot-flushes/night-sweats, mood swings, anxiety, depression, and sexual dysfunction make it difficult to differentiate between symptoms of menopause and hypoglycemia. While it is recognized that transitioning through menopause increases the potential for developing diabetes, there are no recommendations on managing glucose variability or insulin resistance for women with pre-existing diabetes. Increasingly, women using wearable glucose sensor technologies, insulin pumps, and artificial pancreas systems have self-identified increased glucose variability in the data sets provided by wearable digital health technologies. These datasets, collected in real-time from women outside of traditional research settings, would have been unimaginable 20 years ago. Women highlighting the knowledge deficit are driven to learn and share more about menopause. Their quest for clinician support about the impact of hormone replacement therapies (HRT) on glycemic variability, and the associated risk of developing additional comorbidities, further illustrates the importance of this subject. This work uses datasets from wearable sensors, contributed by women with T1D to inform an understanding of their collective perimenopause and menopause journeys. Glucose readings across a period of weeks, leading up to and immediately following the initiation of prescribed medications, have been analyzed to investigate the physiological effects of HRT on the endocrine system of this sample of menopausal T1D women. Self-management and peer support is bridging the research void, which is why there should be more research into this topic.